Form 4: Fortrea Holdings Director Amrit Ray Awarded 38,817 Restricted Stock Units

Fortrea Holdings Inc. Director Amrit Ray was granted 38,817 Restricted Stock Units (RSUs) on June 10, 2025, which will vest in one year subject to continued service.

Summary

• Amrit Ray, a Director of Fortrea Holdings Inc. (FTRE), was granted 38,817 Restricted Stock Units (RSUs).
• The transaction occurred on June 10, 2025, with the RSUs acquired at a price of $0 per unit.
• Each RSU represents the right to receive one share of Fortrea Holdings Inc. Common Stock upon settlement.
• The RSU award vests in its entirety twelve months after June 10, 2025, contingent on Mr. Ray's continued service as a director.
• Following this transaction, Mr. Ray beneficially owns an aggregate of 38,817 RSUs.

Sentiment

Score: 7

Explanation: The document reports a standard equity compensation grant to a director, which is generally a positive sign of alignment and retention. However, it does not contain information about company performance, strategic shifts, or other factors that would significantly impact sentiment beyond a routine insider transaction.

Positives

• The grant of Restricted Stock Units aligns the director's interests with long-term shareholder value by incentivizing stock price appreciation.
• The award is contingent on continued service, promoting retention of key leadership within the company.

Risks

• The vesting of the 38,817 Restricted Stock Units is subject to the reporting person's continued service as a director, meaning the award could be forfeited if service ceases before the vesting date of June 10, 2026.

Future Outlook

The RSU award indicates a future commitment to the company by Director Amrit Ray, with vesting scheduled for June 10, 2026, contingent on his continued service. This aligns his future financial interests with the company's long-term performance.

Industry Context

Equity awards like Restricted Stock Units are a common form of executive and director compensation in publicly traded companies across various industries, including the contract research organization (CRO) and pharmaceutical services sector where Fortrea Holdings operates. They are widely used to align the interests of insiders with long-term shareholder value and incentivize retention of key personnel.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of director compensation is a standard practice in the industry, comparable to compensation structures at peer companies in the pharmaceutical services sector such as IQVIA Holdings Inc. (IQV) or Syneos Health, Inc. (SYNH) (prior to its privatization).
• The specific number of units awarded would typically be benchmarked against peer group compensation data, though this filing does not provide such comparative details.
• A one-year vesting schedule for director equity awards is a common short-to-medium term incentive structure observed across the industry.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value by incentivizing stock price appreciation and continued service, potentially benefiting shareholders through improved governance and performance.
• Employees: No direct impact on general employees is indicated by this specific filing, as it pertains to director compensation.

Next Steps

• Vesting of the 38,817 Restricted Stock Units on June 10, 2026, contingent on Amrit Ray's continued service as a director.

Key Dates

Keywords

Fortrea Holdings Inc., FTRE, Restricted Stock Units, RSU, Insider Transaction, Form 4, Director Compensation, Equity Award, Amrit Ray